Compare CIK & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIK | ANIK |
|---|---|---|
| Founded | 1987 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.7M | 142.5M |
| IPO Year | N/A | 1993 |
| Metric | CIK | ANIK |
|---|---|---|
| Price | $2.82 | $9.49 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 115.4K | ★ 165.0K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 9.03% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $112,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 30.55 |
| 52 Week Low | $2.50 | $7.87 |
| 52 Week High | $3.19 | $18.37 |
| Indicator | CIK | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 45.09 |
| Support Level | $2.81 | $9.76 |
| Resistance Level | $2.85 | $10.17 |
| Average True Range (ATR) | 0.03 | 0.35 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 68.18 | 28.42 |
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations and individuals.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.